Opko Health OPK Diagnostics — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

TEMDiagnostics — Cost of Goods Sold

$100.96M+19.1%

BIOClinical Diagnostics — Cost of goods sold

$181.8M+1.5%

TEC

TECHDiagnostics And Spatial Biology — Cost of Goods Sold

$38.65M+3.9%

ABTDiagnostic Products — Cost of products sold, excluding amortization of intangible assets

$1.24B+7.8%

LHDiagnostics — Supplies Expense

$613.5M+4.6%

NTRAShipping And Handling — Cost of Goods Sold

$13.68M+25.7%

Questions, answered.

What is Opko Health's diagnostics — cost of goods sold?

Opko Health (OPK) reported diagnostics — cost of goods sold of $56.14M in Q1 2026.

How has Opko Health's diagnostics — cost of goods sold changed year-over-year?

Opko Health's diagnostics — cost of goods sold decreased by 33.6% year-over-year, from $84.52M to $56.14M.

What is the long-term trend for Opko Health's diagnostics — cost of goods sold?

Over 3 years (2022 to 2025), Opko Health's diagnostics — cost of goods sold has grown at a -21.2% compound annual growth rate (CAGR), from $627.55M to $307.35M.

What does diagnostics — cost of goods sold mean?

Represents the direct costs attributable to the production of diagnostic tests and the delivery of related laboratory services. This includes expenses such as reagents, laboratory labor, and direct overhead required to generate diagnostic revenue. Monitoring this metric is essential for evaluating the direct production efficiency and margin potential of the diagnostics business.